Gene ontology annotations for LNPEP |
|
Experiment description of studies that identified LNPEP in exosomes |
1 |
Experiment ID |
489 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 6 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
2 |
Experiment ID |
490 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 7 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
3 |
Experiment ID |
491 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 8 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
4 |
Experiment ID |
492 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 9 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
5 |
Experiment ID |
226 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
GAPDH|CD9|FLOT1
|
Enriched markers |
✔
LMNA|H2AFX|ATP5A1|TOMM20
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
Small RNA sequencing (Illumina HiSeq 2000 (Solexa)
|
PubMed ID |
26027894
|
Organism |
Homo sapiens |
Experiment description |
"Quantitative and qualitative analysis of small RNAs in human endothelial cells and exosomes provides insights into localized RNA processing, degradation and sorting" |
Authors |
"Bas W. M. van Balkom, Almut S. Eisele, D. Michiel Pegtel, Sander Bervoets, Marianne C. Verhaar" |
Journal name |
Journal of Extracellular Vesicles
|
Publication year |
2015 |
Sample |
Endothelial cells |
Sample name |
HMEC-1 |
Isolation/purification methods |
Differential ultracentrifugation Sucrose density gradient |
Flotation density |
1.10 g/mL
|
Molecules identified in the study |
miRNA Protein snoRNA lncRNA yRNA snRNA mRNA ncRNA mtRNA vtRNA scaRNA lincRNA |
Methods used in the study |
Small RNA sequencing (Illumina HiSeq 2000 (Solexa) Western blotting |
|
|
6 |
Experiment ID |
363 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
7 |
Experiment ID |
364 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
8 |
Experiment ID |
365 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
9 |
Experiment ID |
488 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD81|CD63|GAPDH|SDCBP|LAMP1|TFRC|UCHL1|FLOT2|LAMP2|FLOT1|ICAM1|RAB5B|CD151|RAB35|TSG101|RAB5A|CD82
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Homo sapiens |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Mesenchymal stem cells |
Sample name |
UCMSC |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
10 |
Experiment ID |
224 |
MISEV standards |
✔
EM|AFM
|
Biophysical techniques |
✔
Alix|TSG101|CD63|CD81
|
Enriched markers |
✔
GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25944692
|
Organism |
Homo sapiens |
Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
Authors |
"Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S" |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Neuroblastoma cells |
Sample name |
SH-SY5Y |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation OptiPrep density gradient |
Flotation density |
1.10 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
11 |
Experiment ID |
211 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
✔
cytochrome c|GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23333927
|
Organism |
Homo sapiens |
Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
Journal name |
J Proteomics
|
Publication year |
2013 |
Sample |
Ovarian cancer cells |
Sample name |
IGROV1 |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.09-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
12 |
Experiment ID |
212 |
MISEV standards |
✔
CEM
|
Biophysical techniques |
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
✔
Cytochrome C|GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23333927
|
Organism |
Homo sapiens |
Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
Journal name |
J Proteomics
|
Publication year |
2013 |
Sample |
Ovarian cancer cells |
Sample name |
OVCAR-3 |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.09-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
13 |
Experiment ID |
231 |
MISEV standards |
✘
|
Biophysical techniques |
✔
Alix|CD63|CD9
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 1 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
14 |
Experiment ID |
232 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
15 |
Experiment ID |
233 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
16 |
Experiment ID |
275 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
✔
AIF
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel sensitive |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.12-1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry/Flow cytometry/Western blotting |
|
|
17 |
Experiment ID |
274 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
✔
AIF
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel resistant |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.18 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Flow cytometry Western blotting |
|
|
18 |
Experiment ID |
834 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
LAMP2|CD63|FLOT1|ITGA2B|ICAM1|CD9|CD151|TFRC|RAB5A|GAPDH|AQP1|TSG101
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35333565
|
Organism |
Homo sapiens |
Experiment description |
LAMP2A regulates the loading of proteins into exosomes |
Authors |
"Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M, Girão H, van Niel G, Pereira P" |
Journal name |
Sci Adv
|
Publication year |
2022 |
Sample |
Retinal pigment epithelial cells |
Sample name |
ARPE-19 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
19 |
Experiment ID |
835 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD63|FLOT1|ITGA2B|ICAM1|CD9|CD151|TFRC|RAB5A|GAPDH|AQP1|TSG101
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35333565
|
Organism |
Homo sapiens |
Experiment description |
LAMP2A regulates the loading of proteins into exosomes |
Authors |
"Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M, Girão H, van Niel G, Pereira P" |
Journal name |
Sci Adv
|
Publication year |
2022 |
Sample |
Retinal pigment epithelial cells |
Sample name |
ARPE-19 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
20 |
Experiment ID |
191 |
MISEV standards |
✘
|
Biophysical techniques |
✔
Alix|CD81|CD9
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20124223
|
Organism |
Homo sapiens |
Experiment description |
Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. |
Authors |
"Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, Lim SK, Sze SK." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2010 |
Sample |
Squamous carcinoma cells |
Sample name |
Squamous carcinoma cell (A431) |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
21 |
Experiment ID |
217 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|CD81|CD9|CD63
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23844026
|
Organism |
Homo sapiens |
Experiment description |
Characterization of human thymic exosomes. |
Authors |
"Skogberg G, Gudmundsdottir J, van der Post S, Sandstrom K, Bruhn S, Benson M, Mincheva-Nilsson L, Baranov V, Telemo E, Ekwall O." |
Journal name |
PLoS One
|
Publication year |
2013 |
Sample |
Thymus |
Sample name |
Normal-Thymus |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for LNPEP |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
STARD3NL |
83930 |
Affinity Capture-MS |
 |
Homo sapiens |
|
2 |
TAS2R19 |
|
Two-hybrid |
 |
Homo sapiens |
|
3 |
GJD3 |
|
Proximity Label-MS |
 |
Homo sapiens |
|
4 |
AP2B1 |
163 |
Co-fractionation |
 |
Homo sapiens |
Proximity Label-MS |
 |
Homo sapiens |
|
5 |
OCLN |
100506658 |
Proximity Label-MS |
 |
Homo sapiens |
|
6 |
METTL7A |
25840 |
Proximity Label-MS |
 |
Homo sapiens |
|
7 |
LAMP3 |
|
Proximity Label-MS |
 |
Homo sapiens |
|
8 |
ATG9A |
79065 |
Proximity Label-MS |
 |
Homo sapiens |
|
9 |
GJA1 |
2697 |
Proximity Label-MS |
 |
Homo sapiens |
|
10 |
SCGB1D4 |
|
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
11 |
REL |
5966 |
Two-hybrid |
 |
Homo sapiens |
|
12 |
CST3 |
1471 |
Affinity Capture-MS |
 |
Homo sapiens |
|
13 |
LGALS1 |
3956 |
Affinity Capture-MS |
 |
Homo sapiens |
|
14 |
HSD17B11 |
51170 |
Proximity Label-MS |
 |
Homo sapiens |
Two-hybrid |
 |
Homo sapiens |
|
15 |
LAMP2 |
3920 |
Proximity Label-MS |
 |
Homo sapiens |
|
16 |
DNAJC25 |
548645 |
Proximity Label-MS |
 |
Homo sapiens |
|
17 |
EDNRB |
1910 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
18 |
FHOD1 |
29109 |
Two-hybrid |
 |
Homo sapiens |
|
19 |
STX4 |
6810 |
Proximity Label-MS |
 |
Homo sapiens |
|
20 |
KIAA1429 |
25962 |
Affinity Capture-MS |
 |
Homo sapiens |
|
21 |
DROSHA |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
22 |
HEATR3 |
55027 |
Affinity Capture-MS |
 |
Homo sapiens |
|
23 |
PRDX3 |
10935 |
Co-fractionation |
 |
Homo sapiens |
|
24 |
DYRK1A |
1859 |
Affinity Capture-MS |
 |
Homo sapiens |
|
25 |
RAB3B |
5865 |
Proximity Label-MS |
 |
Homo sapiens |
|
26 |
BAGE2 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
27 |
SSR1 |
6745 |
Proximity Label-MS |
 |
Homo sapiens |
|
28 |
CD3E |
916 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
29 |
UBQLN1 |
29979 |
Two-hybrid |
 |
Homo sapiens |
|
30 |
BTNL8 |
|
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
31 |
STX6 |
10228 |
Proximity Label-MS |
 |
Homo sapiens |
|
32 |
ST8SIA4 |
7903 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
33 |
PNOC |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
34 |
LGALS9 |
3965 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
35 |
RAB35 |
11021 |
Proximity Label-MS |
 |
Homo sapiens |
|
36 |
GPX8 |
493869 |
Two-hybrid |
 |
Homo sapiens |
|
37 |
ST14 |
6768 |
Affinity Capture-MS |
 |
Homo sapiens |
|
38 |
C5orf28 |
|
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
39 |
EBAG9 |
9166 |
Proximity Label-MS |
 |
Homo sapiens |
|
40 |
CLGN |
1047 |
Affinity Capture-MS |
 |
Homo sapiens |
|
41 |
SSMEM1 |
|
Two-hybrid |
 |
Homo sapiens |
|
42 |
MARCKS |
4082 |
Proximity Label-MS |
 |
Homo sapiens |
|
43 |
LAMTOR1 |
55004 |
Proximity Label-MS |
 |
Homo sapiens |
|
44 |
TNF |
|
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
45 |
LMAN1 |
3998 |
Proximity Label-MS |
 |
Homo sapiens |
|
46 |
RAB5A |
5868 |
Proximity Label-MS |
 |
Homo sapiens |
|
47 |
FCER1G |
2207 |
Two-hybrid |
 |
Homo sapiens |
|
48 |
REEP4 |
|
Two-hybrid |
 |
Homo sapiens |
|
49 |
GGT7 |
2686 |
Two-hybrid |
 |
Homo sapiens |
|
50 |
STOM |
2040 |
Two-hybrid |
 |
Homo sapiens |
|
51 |
LYN |
4067 |
Proximity Label-MS |
 |
Homo sapiens |
|
52 |
RAB4A |
5867 |
Proximity Label-MS |
 |
Homo sapiens |
|
53 |
DNAJC5 |
80331 |
Proximity Label-MS |
 |
Homo sapiens |
|
54 |
GCC1 |
79571 |
Affinity Capture-MS |
 |
Homo sapiens |
|
55 |
SDF2L1 |
23753 |
Affinity Capture-MS |
 |
Homo sapiens |
|
56 |
DIRAS3 |
|
Proximity Label-MS |
 |
Homo sapiens |
|
57 |
FAM19A5 |
25817 |
Affinity Capture-MS |
 |
Homo sapiens |
|
58 |
DNAJB9 |
4189 |
Affinity Capture-MS |
 |
Homo sapiens |
|
59 |
DHFRL1 |
|
Proximity Label-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
60 |
TMEM56 |
|
Two-hybrid |
 |
Homo sapiens |
|
61 |
AQP12B |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
62 |
SEC62 |
7095 |
Proximity Label-MS |
 |
Homo sapiens |
|
63 |
LHFPL5 |
|
Two-hybrid |
 |
Homo sapiens |
|
64 |
ELOVL5 |
60481 |
Proximity Label-MS |
 |
Homo sapiens |
|
65 |
SEC61B |
10952 |
Proximity Label-MS |
 |
Homo sapiens |
|
66 |
ASGR2 |
|
Two-hybrid |
 |
Homo sapiens |
|
67 |
NMS |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
68 |
TMEM35 |
|
Two-hybrid |
 |
Homo sapiens |
|
69 |
CTAG1A |
|
Two-hybrid |
 |
Homo sapiens |
|
70 |
CCL22 |
6367 |
Affinity Capture-MS |
 |
Homo sapiens |
|
71 |
CANX |
821 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
72 |
NDUFA13 |
51079 |
Affinity Capture-MS |
 |
Homo sapiens |
|
73 |
LRRC59 |
55379 |
Proximity Label-MS |
 |
Homo sapiens |
|
74 |
TNKS |
8658 |
Reconstituted Complex |
 |
Homo sapiens |
|
75 |
DUOXA2 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
76 |
DNAJC2 |
27000 |
Affinity Capture-MS |
 |
Homo sapiens |
|
77 |
UNC93A |
|
Two-hybrid |
 |
Homo sapiens |
|
78 |
MGARP |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
79 |
HSD3B7 |
80270 |
Proximity Label-MS |
 |
Homo sapiens |
|
80 |
LGALS9B |
284194 |
Affinity Capture-MS |
 |
Homo sapiens |
|
81 |
ARF6 |
382 |
Proximity Label-MS |
 |
Homo sapiens |
|
82 |
FBXO6 |
26270 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
83 |
AQP3 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
84 |
LGALS7 |
3963 |
Affinity Capture-MS |
 |
Homo sapiens |
|
85 |
TMEM263 |
90488 |
Affinity Capture-MS |
 |
Homo sapiens |
|
86 |
TNKS2 |
80351 |
Affinity Capture-Western |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Two-hybrid |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
|
87 |
HLA-DQA1 |
3117 |
Affinity Capture-MS |
 |
Homo sapiens |
|
88 |
MYO6 |
4646 |
Proximity Label-MS |
 |
Homo sapiens |
|
89 |
RPA3 |
6119 |
Proximity Label-MS |
 |
Homo sapiens |
|
90 |
ATP2A1 |
487 |
Proximity Label-MS |
 |
Homo sapiens |
|
91 |
FBXO2 |
26232 |
Affinity Capture-MS |
 |
Homo sapiens |
|
92 |
CYP2J2 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
93 |
RAB9A |
9367 |
Proximity Label-MS |
 |
Homo sapiens |
|
94 |
TGFA |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
95 |
HYOU1 |
10525 |
Affinity Capture-MS |
 |
Homo sapiens |
|
96 |
Junb |
|
Affinity Capture-MS |
 |
Mus musculus |
|
97 |
RHOB |
388 |
Proximity Label-MS |
 |
Homo sapiens |
|
98 |
LGALS8 |
3964 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
99 |
FATE1 |
|
Two-hybrid |
 |
Homo sapiens |
Two-hybrid |
 |
Homo sapiens |
|
100 |
NAPRT |
93100 |
Affinity Capture-MS |
 |
Homo sapiens |
|
101 |
ANKFY1 |
51479 |
Proximity Label-MS |
 |
Homo sapiens |
|
102 |
GLRA2 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
103 |
SIAE |
54414 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
104 |
SCGB1D1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
105 |
HLA-DRA |
3122 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
106 |
PPM1H |
|
Proximity Label-MS |
 |
Homo sapiens |
|
107 |
CTAG1B |
|
Two-hybrid |
 |
Homo sapiens |
|
108 |
LGALS3 |
3958 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
109 |
LMAN2L |
81562 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
110 |
GPR107 |
57720 |
Affinity Capture-MS |
 |
Homo sapiens |
| | | |